InnovAge Holding Corp. Interest Expense
InnovAge Holding Corp. (INNV) reported Interest Expense of $1.02 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-07
- InnovAge Holding Corp. interest expense for the quarter ending 2024-03-31 was $1.02M, a 152.35% increase year-over-year.
- InnovAge Holding Corp. interest expense for the quarter ending 2023-12-31 was $935.00K, a 319.28% increase year-over-year.
- InnovAge Holding Corp. interest expense for the quarter ending 2023-09-30 was $661.00K, a 9.62% increase year-over-year.
- InnovAge Holding Corp. interest expense for the quarter ending 2023-03-31 was $405.00K, a 42.88% decline year-over-year.
- InnovAge Holding Corp. interest expense for fiscal 2022 was $2.53M, a 84.95% decline from fiscal 2021.
- InnovAge Holding Corp. interest expense for fiscal 2021 was $16.79M, a 14.83% increase from fiscal 2020.
- InnovAge Holding Corp. interest expense for fiscal 2020 was $14.62M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $1.02M 10-Q · filed 2024-05-07 | $1.96M derived: sum of 2 quarters · filed 2024-05-07 | $2.62M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $935.00K 10-Q · filed 2024-02-06 | $1.60M 10-Q · filed 2024-02-06 | ||
| 2023-09-30 | $661.00K 10-Q · filed 2023-11-07 | |||
| 2023-03-31 | $405.00K 10-Q · filed 2024-05-07 | $628.00K derived: sum of 2 quarters · filed 2024-05-07 | $1.23M 10-Q · filed 2024-05-07 | $1.83M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $223.00K 10-Q · filed 2024-02-06 | $826.00K 10-Q · filed 2024-02-06 | $1.42M derived: sum of 3 quarters · filed 2024-02-06 | $2.13M derived: sum of 4 quarters · filed 2024-02-06 |
| 2022-09-30 | $603.00K 10-Q · filed 2023-11-07 | $1.20M derived: sum of 2 quarters · filed 2023-11-07 | $1.91M derived: sum of 3 quarters · filed 2023-11-07 | $2.58M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $596.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $1.30M derived: sum of 2 quarters · filed 2023-05-09 | $1.98M derived: sum of 3 quarters · filed 2023-05-09 | $2.53M 10-K · filed 2022-09-13 |
| 2022-03-31 | $709.00K 10-Q · filed 2023-05-09 | $1.38M derived: sum of 2 quarters · filed 2023-05-09 | $1.93M 10-Q · filed 2023-05-09 | $1.66M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $674.00K 10-Q · filed 2023-02-07 | $1.22M 10-Q · filed 2023-02-07 | $947.00K derived: sum of 3 quarters · filed 2023-02-07 | $5.82M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-09-30 | $547.00K 10-Q · filed 2022-11-08 | $273.00K derived: sum of 2 quarters · filed 2022-11-08 | $5.15M derived: sum of 3 quarters · filed 2022-11-08 | $11.70M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13 | $4.60M derived: sum of 2 quarters · filed 2022-09-13 | $11.16M derived: sum of 3 quarters · filed 2022-09-13 | $16.79M 10-K · filed 2022-09-13 |
| 2021-03-31 | $4.88M 10-Q · filed 2022-05-10 | $11.43M derived: sum of 2 quarters · filed 2022-05-10 | $17.06M 10-Q · filed 2022-05-10 | $20.39M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $6.55M 10-Q · filed 2022-02-09 | $12.19M 10-Q · filed 2022-02-09 | $15.52M derived: sum of 3 quarters · filed 2022-02-09 | $17.88M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | $5.63M 10-Q · filed 2021-11-09 | $8.96M derived: sum of 2 quarters · filed 2021-11-09 | $11.32M derived: sum of 3 quarters · filed 2021-11-09 | |
| 2020-06-30 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23 | $5.69M derived: sum of 2 quarters · filed 2021-09-23 | $14.62M 10-K · filed 2021-09-23 | |
| 2020-03-31 | $2.36M 10-Q · filed 2021-05-11 | $11.29M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |